The relationship between prevention of mother to child transmission of HIV and stakeholder decision making in Uganda: Implications for health policy

Health Policy

Volumn 66, Issue 2, 2003, Pages 199-211

  Kapiriri, Lydia ^a   Robbestad, Bjarne ^a   Norheim, Ole Frithjof ^a  

^a UNIVERSITY OF BERGEN   (Norway)

Author keywords

AIDS; Health care rationing; HIV; International health

Indexed keywords

ANTIRETROVIRUS AGENT; DIURETIC AGENT; NEVIRAPINE; TRICYCLIC ANTIDEPRESSANT AGENT; VASODILATOR AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CHILDHOOD DISEASE; CONTROLLED STUDY; DEPRESSION; DIARRHEA; EVALUATION; EVIDENCE BASED MEDICINE; HEALTH CARE PERSONNEL; HEALTH CARE PLANNING; HEALTH CARE POLICY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; INFECTION PREVENTION; INTERVIEW; MALARIA; MEDICAL DECISION MAKING; PNEUMONIA; POPULATION; RESOURCE MANAGEMENT; RURAL AREA; SMOKING; TECHNIQUE; TUBERCULOSIS; UGANDA; URBAN AREA; VERTICAL TRANSMISSION;

EID: 0242320934     PISSN: 01688510     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8510(03)00062-9     Document Type: Article

References (47)

1. Bryant J.H. Health priority dilemmas in developing countries. Coulter A., Ham C. The global challenge of health care rationing. 2000;Open University Press, London.
2. Marseille E., Kahn G., Mmiro F., Guay L., Musoke P., Fowler G., Jackson B. Cost effectiveness of single dose nevirapine regimen for mothers and babies in sub-Saharan Africa. The Lancet. 354:1999;803-809.
3. Soderlund N., Zwi K., Kinghorn A., Gray G. Prevention of vertical transmission of HIV: analysis of cost-effectiveness of options available in South Africa. British Medical Journal. 318:1999;1650-1656.
4. Health policy statement, Ministry of Health, Kampala, 1999.
5. Uganda, Health policy statement, Ministry of Health, Kampala, 2000.
6. Epidemiological fact sheets on HIV/AIDS and sexually transmitted infections, Uganda UNAIDS/WHO, 2000.
7. Gwatkin DR, Rustein S, Johnson K, Pande R, Wagstaff A. Socio-economic differences in health, nutrition, and population in Uganda. For the HNP/Poverty Thematic Group of the World Bank, Washington DC, 2000.
8. Zwi K., Soderlund N., Schneider H. Cheaper anti-retrovirals to treat AIDS in South Africa. They are at their most cost-effective in preventing mother to child transmission. British Medical Journal. 320:2000;1551-1552.
9. Redman S., Carrick S., Cockburn J., Hirst S. Consulting about priorities for the NHMRC National Breast Cancer Centre: how good is the nominal group technique. Australian and New Zealand Journal of Public Health. 21:(3):1997;250-256.
10. Kellogg WK. http://www.wkkf.org/Publications/evalhdbk/default.html . A Kellogg Foundation Evaluation Handbook, 1998.
11. Green L.W., Kreuter M.W. Health promotion planning, an educational and environmental approach. 1991;96-172 Mayfield, Mountain View, CA.
12. Kapiriri L., Norheim O.F. Whose priority counts? Comparison of community identified health problems and the burden of disease assessed health priorities in a district in Uganda. Health Expectations. 5:(1):2002;55-62.
13. Ham C. Synthesis: what can we learn from international experience? British Medical Bulletin. 51:(4):1995;819-830.
14. Whitehead M. The concepts and principles of equity and health. International Journal of Health Services. 22:(3):1992;429-445.
15. Pereira J. What does equity in health mean? Journal of Social Policy. 22:1993;19-48.
16. Caplan R.L., Light D.W., Daniels N. Benchmarks of fairness: a moral framework for assessing equity. International Journal of Health Services. 29:(4):1999;853-869.
17. Taipale V. Ethics and allocation of health resources - the influence of poverty on health. Acta Oncology. 38:(1):1999;51-55.
18. Murray CJL, Lopez AD. The global burden of disease. World Health Organisation, Harvard School of Public Health, World Bank, 1996.
19. Proceedings from the East Africa burden of disease, cost-effectiveness of health care interventions and health policy regional workshop, Nairobi, Kenya, 1994.
20. Eddy D.M. Comparing benefits and harms: the balance sheet. Journal of American Medical Association. 263:1990;2493. and pp. 2498 and 2501.
21. Eddy D.M. Clinical decision-making: from theory to practice. Guidelines for policy statements: the explicit approach. Journal of American Medical Association. 263:1990;2239-2243.
22. Daniels N., Sabin J. Limits to health care: fair procedures, democratic deliberation, and the legitimacy problem for insurers. Philosophy and Public Affairs. 4:1997;303-350.
23. Daniels N. Accountability for reasonableness. British Medical Journal. 321:2000;1300-1301.
24. http://www3.who.int/whosis/menu.cfm? path=evidence,cea&language= english, downloaded 20.02.02.
25. Newell M.L., Dabis F., Tolley K., Whynes. Cost-effectiveness and cost-benefit in the prevention of mother to child transmission of HIV in developing countries. AIDS. 12:1998;1571-1580.
26. Gundersen SG, What is PMTCT all about? Prevention of mother to child transmission (PMTCT) of HIV. Paper presented at a workshop: Dilemmas facing mothers in the time of AIDS, Oslo, November, 2001.
27. Osborne CM. Scaling up interventions to prevent Mother to child HIV transmission. The vision of the UN inter-agency task team on the prevention of MTCT of HIV (UNAIDS secretariat, UNFPA, UNICEF and WHO). Paper presented at a workshop: Dilemmas facing mothers in the time of AIDS, Oslo, November, 2001.
28. http://www.who.int/chd/publications/imci/ration.html, downloaded, 19.03.2001
29. Uganda demographic and health survey, Kampala, 1995.
30. Jha P., Ousmame B., Ranson K. The cost-effectiveness of forty health interventions in Guinea. Health Policy and Planning. 13:(3):1998;249-262.
31. http://www.who.int/mental_health/topic_depression.html, downloaded, 21.03.2001.
32. Women's mental health. An evidence based review, Geneva, WHO, March, 2000.
33. Revicki D.A., Brown R.E., Keller M.B., Gonzales J., Culpepper L., Hales R.E. Cost-effectiveness of newer antidepressants compared with tricyclic antidepressants in managed care settings. Journal of Clinical Psychiatry. 58:(2):1997;47-58.
34. UNAIDS/WHO. Epidemiological fact sheet on HIV/AIDS and sexually transmitted infections, 2000, Update.
35. http://www.UNICEF.org/statistics (2000) downloaded 25.03.2001.
36. WHO fact sheet on tuberculosis, Geneva, 1996.
37. Dye C., Scheele S., Dolin P. Global burden of tuberculosis. Estimated incidence, prevalence, and mortality by country. Journal of American Medical Association. 82:1999;7.
38. http://tobacco.who.int/en/health/burden.html, downloaded, 10.04.2001.
39. http://www.who.int/gtb/publications/tbrep_96/execsum.html, downloaded, 10.04.2001.
40. International Tobacco Guide, Geneva, 1996.
41. Asma S., Pederson L. Tobacco control in Africa. Opportunities for prevention. Tobacco Control. 8:1999;353-354.
42. WHO fact sheet on malaria, Geneva, 1998.
43. Goodman C.A., Mills A.J. The evidence base on the cost-effectiveness of malaria control measures in Africa. Health Policy and Planning. 14:(4):1999;301-312.
44. http://www.caregiver.org/factsheets/stroke.html, downloaded, 04.04.2001.
45. Edwards R., Unwin N., Mugusi F. Hypertension prevalence and care in an urban and rural area of Tanzania. Journal of Hypertension. 18:(2):2000;145-152.
46. Cooper S.R., Rotimi C.N., Kaufman J.S. Hypertension treatment and control in sub-Saharan Africa: the epidemiological basis for policy. British Medical Journal. 316:1998;614-617.
47. Moore R.D. Cost-effectiveness of combination therapy: 3 years later. Pharmacoeconomics. 17:(4):2000;325-330.